Oxford and Manchester Universities seek Participants for new schizophrenia drug test

ECCENTRIC people, those who believe in the supernatural and others who keep to themselves are being invited to be part of a study.

Oxford and Manchester universities are collaborating in efforts to find a new treatment for schizophrenia. Anyone interested and aged between 18 and 45 should fill out a 74-question survey, the universities say.

They could then be invited to Oxford University’s research centres for further testing and receive up to £340 for taking part.

To participate visit :

http://www.bbmh.manchester.ac.uk/SEP-363856/

or contact the research sites:

If you would like further information about the study, please contact your research site

University of Manchester

Tel: 0161 275 1731

Text: STUDY to 70800

E-mail: SEP@manchester.ac.uk

Oxford University

Tel: 07760 486222

Text: STUDY to 70099

E-mail: sep_study@psych.ox.ac.uk

See the following link for the full story:

The Drug being tested is this one:

SEP-363856 Schizophrenia

Developed in-house (Sunovion Pharmaceuticals Inc.)
SEP-363856 is an antipsychotic with a novel mechanism of action. Compared to existing antipsychotics that are effective for positive symptoms of schizophrenia, this also shows efficacy for the negative symptoms. Even in combination treatment with atypical antipsychotics, extrapyramidal side effects were not observed. High efficacy and improved QOL are expected for the treatment for schizophrenia.
Development stage: Phase I in the U.S.

Source: http://www.ds-pharma.com/rd/clinical/pipeline_profile.html